NeoSoma
Curated by SignalProvider of an AI-based image analysis and decision-making platform for neurooncologist
Overview
Provider of an AI-based image analysis and decision-making platform for neurooncologist. The company has developed an AI-enabled neurooncology platform that assists doctors in clinical management. The company has developed platforms like RANO (Response Assessment Neuro-oncology Criteria) that are made for clinical decision making. It provides 2D image analysis tools for brain tumors. There is an automated version called Neosoma-Glioma Automates RANO. The platform has a medical imaging technology for precise analysis of patients' reports and information. Its products are based and developed on MRI sequences for analysis and modeling.
Key facts
- Founded
- 2019
- Headquarters
- Boston, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 5 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view